Objectives-The purpose of this study was to explore the association between mesh location and de novo stress urinary incontinence (SUI) after transvaginal mesh procedures.
T he benefits of transvaginal mesh procedures in the anatomic support of recurrent or advanced cystocele are supported in the current literature. [1] [2] [3] [4] However, de novo stress urinary incontinence (SUI) is not uncommon after transvaginal mesh procedures for pelvic organ prolapse, [1] [2] [3] [5] [6] [7] [8] and surgery for SUI is among the most common indications for reoperation after transvaginal mesh procedures. 9 The possible mechanisms of de novo SUI after transvaginal mesh procedures include release of urethral obstruction, 10 unmasking of urethral hypermobility or intrinsic sphincteric deficiency, 10 overcorrection of the bladder neck and anterior vagina, 3 ,11 a urethral sphincter deficiency linked to urethral supportive or neural defects, 12, 13 as well as placement of the distal transvaginal mesh that limits bladder and urethral mobility. 14 It has been reported that proper urethral compression and an optimal suburethral tape location contribute to postoperative continence. 15 A net curative effect of transvaginal mesh on SUI has been reported, hypothetically through some compressive effect on the urethra. 16 Limited knowledge is available regarding the effect of the transvaginal mesh location on de novo SUI. Given the crucial role of a suburethral tape location at the junction of the middle and distal thirds in optimal postoperative outcomes, 17, 18 we hypothesized that the supportive area of the urethra by transvaginal mesh may contribute to de novo SUI after transvaginal mesh procedures. This study aimed to explore the associations between mesh location and de novo SUI by comparing postoperative sonographically based mesh locations between women who did and did not report de novo SUI at 12-month postoperative assessments.
Materials and Methods
We retrospectively analyzed a database of women who had received the Perigee system (American Medical Systems, Minnetonka, MN) for stage III or greater cystocele according to the Pelvic Organ Prolapse Quantification (POP-Q) system at the Department of Obstetrics and Gynecology of Cathay General Hospital between November 2007 and January 2014. Only data for women who neither reported SUI at preoperative assessments nor had received concomitant anti-incontinence surgery were included for analyses. Women with previous pelvic organ prolapse surgeries, previous suburethral tape procedures, or incomplete clinical or sonographic information were excluded. Based on these criteria, data from 83 women were included in the analyses. The study cohort was divided into continent women (group 1; n 5 54) and incontinent women (group 2; n 5 29) according to the continence status assessed at the 12-month follow-up. Woman were considered to have SUI if they provided a positive response to the clinical interview addressing involuntary loss of urine on effort or physical exertion (eg, sporting activities) or on sneezing or coughing. Occult SUI was excluded by showing no urinary leakage on a stress test with prolapse reduction on a pelvic examination. This study's design was approved by the Institutional Review Board of Cathay General Hospital (CGH-P102071). The methods, definitions, and units in this study all conformed to the standards recommended by the International Continence Society, 19 ,20 unless otherwise specified.
All surgical procedures were performed by a single investigator (W.-C.H.) with the patient under general anesthesia, and the Perigee procedures were performed according to the manufacturer's instructions. Defects in the apical vaginal compartment, posterior vaginal compartment, or both compartments were simultaneously repaired, depending on the sites and POP-Q stages of the pelvic floor defects.
A single investigator (W.-C.H.) conducted 4-dimensional (4D) sonography using an introital approach with an iU22 ultrasound system (Philips Healthcare, Bothell, WA) and a 3-9-MHz transvaginal volume transducer (858 angle at 2-3 Hz) when the woman was in the lithotomy position. The 4D sonographic volumes were stored on digital video disks for offline analyses with QLAB 6.0 software (Philips Healthcare). The mesh location was evaluated as the percentage of the urethra covered by mesh, which was defined as the number calculated by dividing the portion of the urethral length covered by mesh (the distance from the bladder neck to the point of the urethra, which was indicated by an imaginary line at the level of the lower [caudal] mesh end and perpendicular to the urethra) by the total urethral length (the distance from the bladder neck to the external urethral meatus) in the sagittal plane, with the bladder neck and the external urethral meatus representing the 0 and 100th percentiles, respectively ( As preliminary data on the mesh location in association with de novo SUI after Perigee procedures were not available at the start of the study, we used an average mesh percentile of 35% and an SD of 15% to calculate the sample size. With a 2-sided a of .05 and power of 80%, a sample size of 28 per group was required to detect a 7% difference in the mesh location, represented as the percentage of the urethra covered by mesh.
Continuous and categorical data were presented as mean 6 standard deviation and number (percent), respectively. The test-retest reproducibility of the sonographic measurements was investigated in the stored data sets of 20 women who had complete sonographic assessments 12 months after isolated Perigee procedures. The intraobserver reliability was assessed by a single investigator (W.-C.H.), who performed 2 series of offline postprocessing analyses with an interval of 7 to 28 days and was blinded to the previous analysis. The interobserver reliability was assessed by 2 independent investigators (W.-C.H. and J.-M.Y.). The relative reliability was determined by calculating the intraclass correlation coefficient and 95% confidence interval for both intraobserver and interobserver reliabilities. Intraclass correlation coefficient values of less than 0.20 were considered poor; 0.21 to 0.40, fair; 0.41 to 0.60, moderate; 0.61 to 0.80 good; and 0.81 to 1.00, very good. 21 The absolute reliability was defined as the standard error of measurement (SEM) and the minimal detectable change calculated by using a 95% confidence interval. The minimal detectable change was calculated as SEM 3 1.96 3 ͱ2. 22 The clinical manifestations and mesh locations were compared between groups 1 and 2 by the Mann-Whitney U test or the Yates corrected v 2 test, as appropriate. All analyses were performed with using SPSS version 17.0 software for Windows (IBM Corporation, Armonk, NY), and the statistical significance was set at P < .05 for all analyses.
Results
The data for 102 women who did not report SUI at baseline and underwent the Perigee system without concomitant anti-incontinence procedures, previous POP surgery, or previous anti-incontinence procedures were reviewed, and those of 86 women (84.3%) were available for the 12-month follow-up. After 3 women were excluded for missing clinical information, 83 women (81.4%) were eligible for analyses. Among the 83 women, 1 (1.2%) presented with pain, 5 (6.0%) with new-onset urgency, and 9 (10. %) with mesh exposure at the 12-month follow-up, respectively.
The mean age 6 SD of the 83 included patients was 67.4 6 10.3 years; the median parity was 4; and the mean body mass index was 24.3 6 2.9 kg/m 2 . Women in the groups did not significantly differ in patient characteristics, preoperative POP-Q points Ba (most distal position of the remaining upper anterior vaginal wall), C (most distal edge of the cervical or vaginal cuff scar), covered by mesh, 26.2% ). In the 4D images, panels 1, 2, and 3 represent the sagittal, coronal, and axial views of the pelvic structure and mesh, respectively. The quality of 2D images may be degraded because they were captured frames from the 4D volume. Abbreviations are as in Figure 1. and Bp (most distal position of the remaining upper posterior vaginal wall), and concomitant apical or posterior vaginal surgery ( Table 1) .
The intraclass correlation coefficient, 95% confidence interval, SEM, and minimal detectable change values for intraobserver and interobserver reliability are presented in Table 2 . Except for very good interobserver reliability for the coughing mesh location, the intraobserver and interobserver reliabilities for other sonographic measurements were very good and good, respectively ( Table 2 ). The minimal detectable change values for all sonographic measurements were small, ranging from 2.77% to 3.96% (Table 2) .
At the 12-month follow-up, continent and incontinent women had comparable positions for POP-Q points Ba, C, and Bp, with women in both groups showing stage 0 pelvic organ prolapse. Incontinent women (group 2) had a smaller mesh location than continent women (group 1) during straining, indicating a more proximal straining mesh location relative to the lower urinary tract. Meanwhile, the mesh locations during resting, coughing, and squeezing did not significantly differ between the groups (Table 3) .
Discussion
This study used sonography to explore the associations between mesh location and de novo SUI after Perigee procedures. We exclusively included data for women who were urinary continent preoperatively and received transvaginal mesh procedures without concomitant antiincontinence procedures. The mesh locations were Data are presented as mean 6 SD and were compared by the Mann-Whitney U test. The mesh location was evaluated as the percentage of the urethra covered by mesh, which was defined as the number calculated by dividing the portion of the urethral length covered by mesh by the total urethral length in the sagittal planes, with the bladder neck and the external urethral meatus representing the 0 and 100th percentiles, respectively.
quantitatively expressed as a percentage of the urethra covered by mesh on sonography during resting, straining, coughing, and squeezing. At the 12-month followup, women reporting de novo SUI had a more proximal straining mesh location than those remaining urinary continent. Sonography is currently considered advantageous in investigating postoperative outcomes after transvaginal mesh procedures. 16, 23, 24 The Perigee mesh has 4 arms for anchorage, including distal arms to position the mesh caudally at the bladder neck and proximal arms to extend the mesh cranially at the vaginal apex. 23, 24 On sonography, the mesh appears as an echogenic linear or curvilinear structure, and it is usually located posterior to the bladder neck and caudal to the trigone and the posterior bladder neck. 16 Theoretically, on sonography, the lower and upper parts of the mesh represent the distal and proximal mesh portions that are respectively interposed by the superior and inferior trocars to support the bladder neck and vaginal apex. In real practice, it is not uncommon that the lower mesh parts can be observed as located "below the bladder neck" along the proximal urethra, suggesting that the mesh may exert a supportive effect on the "proximal" urethra. In addition, visualization of the entire transvaginal mesh on sonography is not always achievable in real practice. To explore the potential contributions of the transvaginal mesh location to de novo SUI, we therefore focused on the location of the distal mesh end.
Mesh location may play a crucial role in de novo SUI after Perigee procedures. This study found an association between a more proximal straining mesh location relative to the lower urinary tract and de novo SUI, which was suggested by the findings that women reporting de novo SUI had a mean straining percentage of the urethra covered by mesh of 28.5% compared with 35.2% in continent women. It has been reported that a proximally located suburethral tape is associated with persistent SUI symptoms 25 and that an optimal suburethral tape location at the 40th to 70th percentiles leads to higher surgical success. 15, 17, 26 By analogy with the mechanism of the suburethral tape, transvaginal mesh may provide a remedial effect on the emergence of de novo SUI by interposing the mesh on an optimal location when urethral obstruction is released or urethral hypermobility is unmasked after transvaginal mesh procedures. Furthermore, our findings disclosing a more proximal straining mesh location relative to the lower urinary tract in women with de novo SUI might indicate limited or less support of the proximal urethra during straining. Therefore, placement of transvaginal mesh with the lower (caudal) end just beneath the bladder neck, complying with the manufacturer's instructions, could be associated with de novo SUI. However, this association would require further study to clarify.
A significantly more proximal mesh location during straining, rather than during resting, coughing, or squeezing, observed in women reporting de novo SUI may highlight the protective role of transvaginal mesh during stress. Since SUI is an event associated with increased intra-abdominal pressures, our findings disclosing the associations between the straining mesh location and de novo SUI are therefore considered reasonable. Transvaginal mesh has been considered more clearly visible during the Valsalva maneuver on sonography, and it behaves like an oversized trigonal sling, rotates around the fulcrum of the symphysis pubis during straining, and results in some limited compressive effect on the urethra, which may contribute to a cure or improvement of stress leakage. 16 The lack of differences in the coughing and squeezing mesh locations between the groups in this study may have been presumptively influenced by involuntary and voluntary pelvic floor muscle function, respectively.
The findings of this study may be limited by its retrospective and small-sized design. Although power analyses based on the average values for straining mesh locations of women in the groups yielded statistical power of 84.3%, a larger-scale study would be required to elucidate the roles of mesh locations in SUI after transvaginal mesh procedures. Additionally, different patients' postures during clinical assessments, such as standing and supine, might yield different results. Moreover, both the surgery and sonography were performed by the same investigator, thus introducing a potential bias. Furthermore, the homogeneity of the study population may limit the generalization of our findings to local women. Finally, the compressive effects of the Perigee system on the urethra were not investigated in this study. An association between a narrower gap between the mesh and symphysis pubis and postoperative urinary continence has been found after transvaginal mesh procedures, 16 suggesting that that the mesh is likely to be closer to the urethra, which potentially implies a greater degree of urethral compression during the Valsalva maneuver. Nevertheless, a standardized method for assessing transvaginal mesh functionality is currently lacking. We hypothesized that the mesh distance to the urethra measured by perpendicular lines would help survey the compressive effects of the mesh.
In conclusion, sonography appears to be a simple and effective tool in investigating the transvaginal mesh location. This study revealed that a more proximal straining mesh location relative to the lower urinary tract was associated with de novo SUI after Perigee procedures.
